Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 24, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Recurrent Acute PancreatitisChronic Pancreatitis
Interventions
DRUG

Simvastatin

40Mg Oral Tablet

DRUG

Placebo

Matching Simvastatin Placebo tablet

Trial Locations (2)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

94305

RECRUITING

Stanford University, Stanford

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Cedars-Sinai Medical Center

OTHER